Apotea AB (publ)CHIX:APOTES 18 PS Ratio is 0.92 as of Jul. 11, 2026, which is 28% below its 10-year median of 1.27. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 659 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 62.06% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Apotea AB (publ)'s share price is kr65.20.
Apotea AB (publ)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr70.94. Hence, Apotea AB (publ)'s PS Ratio for today is 0.92.
The historical rank and industry rank for Apotea AB (publ)'s PS Ratio or its related term are showing as below:
CHIX:APOTEs'
s PS Ratio Range Over the Past 10 Years
Min: 0.82 Med: 1.27 Max: 1.81
Current: 1.09
During the past 5 years, Apotea AB (publ)'s highest PS Ratio was 1.81. The lowest was 0.82. And the median was 1.27.
CHIX:APOTEs's PS Ratio is ranked better than 62.06% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.48
vs CHIX:APOTEs: 1.09
During the past 5 years, Apotea AB (publ)'s highest 3-Year average Revenue per Share Growth Rate was 13.80% per year. The lowest was 13.20% per year. And the median was 13.50% per year.
Back to Basics: PS Ratio
Apotea AB (publ) (CHIX:APOTEs) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Apotea AB (publ) PS Ratio Related Terms
Apotea AB (publ) PS Ratio Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s PS Ratio distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Apotea AB (publ)'s Share Price of today is kr65.20. Apotea AB (publ)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr70.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Apotea AB (publ) (CHIX:APOTES) has a PS Ratio of 0.92 as of Jul. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Apotea AB (publ) and its competitors. This is 28% below median its historical median of 1.27. Over the past decade, Apotea AB (publ)'s PS Ratio has ranged from 0.82 to 1.81. According to the industry distribution chart, Apotea AB (publ) ranks #250 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 37.9%.
Is Apotea AB (publ)'s PS Ratio too high?
Apotea AB (publ)'s current PS Ratio of 0.92 is 28% below median its 10-year median of 1.27. Over the past 10 years, this metric has ranged from a low of 0.82 to a high of 1.81. The Healthcare Providers & Services industry median PS Ratio is 1.48. Apotea AB (publ)'s value of 0.92 is 37.8% below this industry median. Based on the distribution chart, Apotea AB (publ) ranks #250 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #250 out of 659 companies for PS Ratio. This puts Apotea AB (publ) in the upper half of its industry. The industry median PS Ratio is 1.48. Apotea AB (publ)'s value of 0.92 is 37.8% below this benchmark. Historically, Apotea AB (publ)'s own PS Ratio has ranged from 0.82 to 1.81 over the past decade. While the company's 10-year median is 1.27 vs. the industry median of 1.48, Apotea AB (publ) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.48, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current PS Ratio of 0.92 is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current PS Ratio is 0.92, which is 28% below median its own 10-year median of 1.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current PS Ratio of 0.92. The current PS Ratio is 0.92, which is 28% below median its 10-year median of 1.27 and 37.8% below the Healthcare Providers & Services industry median of 1.48. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current PS Ratio is 0.92 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for CHIX:APOTES
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:APOTES has been successfully added to your 
